Denali Therapeutics Inc. Common Stock
$20.40
Market Cap
$3.26B
Shares Outstanding
159.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Dec 8, 2017
Round Lot
100
Locale
US
Day Open
$20.40
Day High
$20.46
Day Low
$19.87
Volume
923.5K
VWAP
$20.22
Prev Close
$20.38
Transactions
--
Acc. Volume
--
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
Denali Therapeutics Inc. Common Stock (DNLI) closed the 2026-09-16 session at $20.40, up 0.10% versus the previous close (+0.02). The stock opened at $20.40 and traded between $19.87 and $20.46 during that session. Session trading volume was 924K shares. The volume-weighted average price (VWAP) is $20.22.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
Denali Therapeutics Inc. Common Stock has a market capitalization of $3.26 billion. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. DNLI is listed on the XNAS exchange. The company employs approximately 507 people. Denali Therapeutics Inc. Common Stock is headquartered in SOUTH SAN FRANCISCO, CA. The recorded listing date is 2017-12-08.
On this page you can find market DNLI stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.